Access our cardiometabolic and lipids hub featuring the latest clinical guidance documents, courses, and resources to improve your practice, advance your medical knowledge, and strengthen your patient care.
Cardiometabolic and Lipids
Online Education
- Yes
The Metabolic Paradox: Understanding the Interplay Between Obesity and MASLD/MASH Series
Starts 9/24/2025 | Expires 11/19/2026
Advance your MASLD and MASH clinical approach through our complimentary 4-part educational series launching September 24, 2025, covering strategies in epidemiology and pathophysiology, diagnostic and team-based screening approaches, comprehensive treatment and coordinated management, and advanced management with future directions.
- Yes
The Kidney in Cardiometabolic Diseases
CME : 1 | MOC : 1
Starts 9/12/2025 | Expires 9/12/2026
Kidney health plays a critical role in the prevention and management of cardiometabolic disorders, including diabetes, heart failure, and cardiovascular disease. This complimentary course explores how renal dysfunction influences disease progression and equips you with practical tools for integrated, patient-centered care.
- Yes
When Triglycerides Skyrocket: Recognizing and Treating Severe Hypertriglyceridemia
CME : 1 | MOC : 1
Live 10/31/2025 at 11:00 AM EDT – 12:00 PM EDT
This complimentary live webinar equips clinicians with the knowledge and tools to recognize and treat severe hypertriglyceridemia, focusing on timely diagnosis, effective management, and evidence-based treatment strategies.
- Yes
CME : 1 | MOC : 1
Live 10/24/2025 at 1:00 PM EDT – 2:00 PM EDT
This complimentary live webinar guides clinicians in diagnosing, managing, and treating homozygous familial hypercholesterolemia (HoFH).
- Yes
AACE Rare Diseases and Hormone Disorders 2025: Pathways to Diagnosis
CME : 6 | MOC : 6
Starts 10/3/2025 | Expires 10/3/2026
Register for our Rare Diseases and Hormone Disorders webinar series covering rare endocrine conditions and hormone disorders:
- Thyroid Eye Disease
- Hypoparathyroidism
- Homozygous Familial Hypercholesterolemia
- Severe Hypertriglyceridemia
- Congenital Adrenal Hyperplasia
- Polycystic Ovary Syndrome
- No
AACE Certificate: Dyslipidemia and Lipids Management
CME : 6 | MOC : 6
Starts 9/3/2025 | Expires 9/3/2027
This certificate program equips health care professionals with the knowledge to improve risk assessment, apply evidence-based therapies, and provide personalized treatment to optimize lipid management and enhance cardiovascular outcomes.
$295 | Informed Members - $235 | Engaged Members - $175 | Fellow Members $115
- No
CME : 6 | MOC : 6
December 10–11, 2025
Join us virtually on December 10–11, 2025, to explore the newest AACE clinical guidance documents presented by the experts who created them. This two-evening virtual CME event offers practical, case-based learning to help you implement evidence-based care in obesity, dyslipidemia, multiple endocrine neoplasia, and menopause management.
- No
April 22–24, 2026
Mark your calendars for our 2026 AACE Annual Meeting taking place April 22-24, at Caesars Forum in Las Vegas, Nevada. Call For Abstracts are open from August 15 to December 1, 2025.
More details and registration information will be available this fall.
- No
AACE Annual Meeting 2025 On Demand
CME : 51.75 | MOC : 51.75
Starts 6/23/2025 | Expires 4/1/2026
Didn't make it to the AACE 2025 Annual Meeting? Access all the invaluable insights and groundbreaking discoveries with our on-demand session recordings.
$999 | Informed Member - $799 | Engaged Member - $599 | Fellow Member - $499
Clinical Guidance
2025 Clinical Practice Guideline for the Pharmacologic Management of Adults with Dyslipidemia
This guideline was developed by a multidisciplinary task force and uses the GRADE framework to provide evidence-based recommendations regarding cardiovascular risk assessment, benefits and harms of newer medications, and treatment goals with a focus on patient-important outcomes.
AvoMD Integrates AACE Clinical Guidance
AvoMD, a software platform that brings clinical evidence into the workflow to help clinicians streamline decisions and save time, has partnered with AACE to integrate clinical guidance documents into the AvoMD platform.
2022 Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings
This guideline provides evidence-based recommendations regarding the diagnosis and management of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) to endocrinologists, primary care clinicians, health care professionals, and other stakeholders.